Stock analysts at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued to investors on Monday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Stock Down 1.4 %
Shares of NASDAQ MDRX opened at $10.84 on Monday. The firm’s 50-day moving average price is $9.71 and its 200-day moving average price is $9.44. Veradigm has a 52-week low of $5.01 and a 52-week high of $12.66.
Hedge Funds Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- The 3 Best Retail Stocks to Shop for in August
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Why Invest in 5G? How to Invest in 5G Stocks
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
